Ohr Pharmaceutical Inc. (OTC BB.OHRP) is a pharmaceutical company dedicated
to the development of first in class drugs for underserved therapeutic needs. Ohr is focused on the development of two drugs, OHR/AVR 118 for the treatment of Cachexia and EVIZONTM for the treatment of wet-AMD.